NN6.DE Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 18:36):

NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally...

Stats
Šios dienos apimtis	1 470.00
Vidutinė apimtis	9 194.00
Rinkos kapitalizacija	23.68M
EPS	€0 ( 2020-07-29 )
Last Dividend	€0.150 ( 2023-06-16 )
Next Dividend	€0 ( N/A )
P/E	-3.60
ATR14	€0 (0.00%)

Nanorepro AG Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Nanorepro AG Finansinės ataskaitos

Annual	2022
Pajamos:	€38.49M
Bruto pelnas:	€9.90M (25.73 %)
EPS:	€-0.290

FY	2022
Pajamos:	€38.49M
Bruto pelnas:	€9.90M (25.73 %)
EPS:	€-0.290

FY	2021
Pajamos:	€162.79M
Bruto pelnas:	€56.64M (34.79 %)
EPS:	€3.19

FY	2020
Pajamos:	€16.93M
Bruto pelnas:	€7.63M (45.07 %)
EPS:	€0.182

Financial Reports:

No articles found.

Nanorepro AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€0 (N/A)	€0.150 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Nanorepro AG Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.98 - low (32.31%) | Divividend Growth Potential Score: 2.56 - Decrease likely (48.85%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.500	2022-05-02
Last Dividend	€0.150	2023-06-16
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	€0.650	--
Avg. Dividend % Per Year	0.00%	--
Score	1.5	--
Div. Sustainability Score	3.98
Div.Growth Potential Score	2.56
Div. Directional Score	3.27	--

Next Divdend (Est)
(2025-03-31)

€0 Estimate 3.00 %

Dividend Stability

0.24 Very Poor

Dividend Score

1.50

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
TA1.DE	Ex Dividend Knight	2023-06-12	Annually	0.00%
DEF.DE	Ex Dividend Knight	2023-07-24	Annually	0.00%
MMM.DE	Ex Dividend Junior	2023-08-18	Quarterly	0.00%
4I1.DE	Ex Dividend Knight	2023-09-26	Quarterly	0.00%
VVD.DE	Ex Dividend Knight	2023-05-09	Annually	0.00%
EVK.DE	Ex Dividend Junior	2023-06-01	Annually	0.00%
OMV.DE	Ex Dividend Knight	2023-06-06	Annually	0.00%
AMG.DE	Ex Dividend Knight	2023-08-17	Quarterly	0.00%
HAW.DE	Ex Dividend Junior	2023-06-13	Annually	0.00%
RIO1.DE	Ex Dividend Knight	2023-08-10	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.472	1.500	-9.44	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.149	1.200	-4.98	-5.97	[0 - 0.3]
returnOnEquityTTM	-0.146	1.500	-2.73	-4.10	[0.1 - 1]
payoutRatioTTM	-0.294	-1.000	-2.94	2.94	[0 - 1]
currentRatioTTM	43.30	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	38.03	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	31.32	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0000000	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.614	2.00	9.80	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.613	2.00	9.69	10.00	[0 - 20]
debtEquityRatioTTM	0.0000000	-1.500	10.00	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.194	1.000	-0.108	-0.108	[0.2 - 0.8]
operatingProfitMarginTTM	-0.692	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	7 917 300	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.316	0.800	-1.225	-0.980	[0.5 - 2]
Total Score				3.98

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-3.62	1.000	-0.466	0	[1 - 100]
returnOnEquityTTM	-0.146	2.50	-1.756	-4.10	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.613	2.00	9.80	10.00	[0 - 30]
dividendYielPercentageTTM	8.13	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.614	2.00	9.80	10.00	[0 - 30]
payoutRatioTTM	-0.294	1.500	-2.94	2.94	[0 - 1]
pegRatioTTM	-0.0158	1.500	-3.44	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.568	1.000	10.00	0	[0.1 - 0.5]
Total Score				2.56

Nanorepro AG

NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, including allergy, family planning, and preventive healthcare line products; point of care testing products for hospitals and medical practices for detection of HIV, human cardiac Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as rapid SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women through online shops, as well as through pharmacies. The company is headquartered in Marburg, Germany.